Items where Author is "Harris, M"
Up a level |
Number of items: 28.
2018
Guise, A;
Witzel, TC;
Mandal, S;
Sabin, C;
Rhodes, T;
Nardone, A;
Harris, M;
(2018)
A qualitative assessment of the acceptability of hepatitis C remote self-testing and self-sampling amongst people who use drugs in London, UK.
BMC infectious diseases, 18 (1).
p. 281.
ISSN 1471-2334
DOI: https://doi.org/10.1186/s12879-018-3185-7
Harris, M;
Bonnington, O;
Harrison, G;
Hickman, M;
Irving, W;
HepCATT team;
, COLLABORATORS;
Roberts, K;
Waldron, CA;
Bevan, J;
+37 more...
Simpson, C;
Homan, C;
Reeve, D;
Hathaway, C;
Purcell, S;
Oelbaum, S;
Whitfield, J;
Jennings, S;
Dreha, R;
Byrne, T;
Thomas, D;
Fraser, E;
Toyne, K;
Newton, P;
Hensley, F;
Hewish, S;
Rutkowski, R;
Christian, A;
Smith, S;
Ward, E;
Rhodes, T;
Lattimore, S;
Mandal, S;
Simmons, R;
Sreedharan, A;
Murray, K;
Richardson, P;
Caldwell, H;
Gore, R;
Hughes, A;
Walters, C;
Orton, A;
Lee, P;
Ryder, S;
Thomson, B;
Montgomery, A;
Foster, G;
(2018)
Understanding hepatitis C intervention success-Qualitative findings from the HepCATT study.
Journal of viral hepatitis.
ISSN 1352-0504
DOI: https://doi.org/10.1111/jvh.12869
Item availability may be restricted.
Harris, M;
Brathwaite, R;
McGowan, CR;
Ciccarone, D;
Gilchrist, G;
McCusker, M;
O'Brien, K;
Dunn, J;
Scott, J;
Hope, V;
(2018)
'Care and Prevent': rationale for investigating skin and soft tissue infections and AA amyloidosis among people who inject drugs in London.
Harm reduction journal, 15 (1).
p. 23.
ISSN 1477-7517
DOI: https://doi.org/10.1186/s12954-018-0233-y
Harris, M;
Brathwaite, R;
Scott, J;
Gilchrist, G;
Ciccarone, D;
Hope, V;
McGowan, CR;
(2018)
Drawing attention to a neglected injecting-related harm: A systematic review of AA-amyloidosis among people who inject drugs.
Addiction (Abingdon, England).
ISSN 0965-2140
DOI: https://doi.org/10.1111/add.14257
Item availability may be restricted.
Harris, M;
Rhodes, T;
(2018)
"It's Not Much of a Life": The Benefits and Ethics of Using Life History Methods With People Who Inject Drugs in Qualitative Harm Reduction Research.
Qualitative health research.
p. 1049732318764393.
ISSN 1049-7323
DOI: https://doi.org/10.1177/1049732318764393
Item availability may be restricted.
Harris, M;
Rhodes, T;
(2018)
Caring and curing: Considering the effects of hepatitis C pharmaceuticalisation in relation to non-clinical treatment outcomes.
The International journal on drug policy, 60.
pp. 24-32.
ISSN 0955-3959
DOI: https://doi.org/10.1016/j.drugpo.2018.07.015
Full text not available from this repository.
McGowan, CR;
Harris, M;
Platt, L;
Hope, V;
Rhodes, T;
(2018)
Fentanyl self-testing outside supervised injection settings to prevent opioid overdose: Do we know enough to promote it?
The International journal on drug policy, 58.
pp. 31-36.
ISSN 0955-3959
DOI: https://doi.org/10.1016/j.drugpo.2018.04.017
Rhodes, T;
Lancaster, K;
Harris, M;
Treloar, C;
(2018)
Evidence-making controversies: the case of hepatitis C treatment and the promise of viral elimination.
Critical public health.
pp. 1-14.
ISSN 0958-1596
DOI: https://doi.org/10.1080/09581596.2018.1459475
Full text not available from this repository.
2017
Bonnington, O;
Harris, M;
(2017)
Tensions in relation: How peer support is experienced and received in a hepatitis C treatment intervention.
The International journal on drug policy.
ISSN 0955-3959
DOI: https://doi.org/10.1016/j.drugpo.2017.05.031
Grebely, J;
Bruneau, J;
Bruggmann, P;
Harris, M;
Hickman, M;
Rhodes, T;
Treloar, C;
International Network on Hepatitis in Substance Users;
International Network on Hepatitis in Substance Users;
(2017)
Elimination of hepatitis C virus infection among PWID: The beginning of a new era of interferon-free DAA therapy.
The International journal on drug policy, 47.
pp. 26-33.
ISSN 0955-3959
DOI: https://doi.org/10.1016/j.drugpo.2017.08.001
Full text not available from this repository.
Harris, M;
(2017)
Managing expense and expectation in a treatment revolution: Problematizing prioritisation through an exploration of hepatitis C treatment 'benefit'.
The International journal on drug policy.
ISSN 0955-3959
DOI: https://doi.org/10.1016/j.drugpo.2017.03.015
Lazarus, JV;
Safreed-Harmon, K;
Stumo, SR;
Jauffret-Roustide, M;
Maticic, M;
Reic, T;
Schatz, E;
Tallada, J;
Harris, M;
Hep-CORE Study Group;
(2017)
Restrictions on access to direct-acting antivirals for people who inject drugs: The European Hep-CORE study and the role of patient groups in monitoring national HCV responses.
The International journal on drug policy.
ISSN 0955-3959
DOI: https://doi.org/10.1016/j.drugpo.2017.05.054
Full text not available from this repository.
Lazarus, JV;
Stumo, SR;
Harris, M;
Hendrickx, G;
Hetherington, KL;
Maticic, M;
Jauffret-Roustide, M;
Tallada, J;
Simojoki, K;
Reic, T;
+2 more...
Safreed-Harmon, K;
Hep-CORE Study Group;
(2017)
Hep-CORE: a cross-sectional study of the viral hepatitis policy environment reported by patient groups in 25 European countries in 2016 and 2017.
Journal of the International AIDS Society, 21 Suppl 2.
e25052.
ISSN 1758-2652
DOI: https://doi.org/10.1002/jia2.25052
Lewer, D;
Harris, M;
Hope, V;
(2017)
Opiate Injection-Associated Skin, Soft Tissue, and Vascular Infections, England, UK, 1997-2016.
Emerging infectious diseases, 23 (8).
pp. 1400-1403.
ISSN 1080-6040
DOI: https://doi.org/10.3201/eid2308.170439
McGowan, CR;
Viens, AM;
Harris, M;
Rhodes, T;
(2017)
Risk Environments and the Ethics of Reducing Drug-Related Harms.
The American journal of bioethics, 17 (12).
pp. 46-48.
ISSN 1526-5161
DOI: https://doi.org/10.1080/15265161.2017.1388870
Item availability may be restricted.
2016
Harris, M;
Ward, E;
Gore, C;
(2016)
Finding the undiagnosed: a qualitative exploration of hepatitis C diagnosis delay in the United Kingdom.
Journal of viral hepatitis.
ISSN 1352-0504
DOI: https://doi.org/10.1111/jvh.12513
Full text not available from this repository.
Schatz, E;
Schiffer, K;
Maher, M;
Harris, M;
Roca, XM;
Maticic, M;
Leicht, A;
(2016)
The Berlin Hepatitis C Manifesto: access to prevention, testing, treatment and care for people who use drugs.
Hepatology, medicine and policy, 1 (1).
p. 14.
ISSN 2059-5166
DOI: https://doi.org/10.1186/s41124-016-0021-9
2015
Ciccarone, D;
Harris, M;
(2015)
Fire in the vein: Heroin acidity and its proximal effect on users' health.
The International journal on drug policy.
ISSN 0955-3959
DOI: https://doi.org/10.1016/j.drugpo.2015.04.009
Full text not available from this repository.
Harris, M;
(2015)
"Three in the Room": Embodiment, Disclosure, and Vulnerability in Qualitative Research.
Qualitative health research.
ISSN 1049-7323
DOI: https://doi.org/10.1177/1049732314566324
Full text not available from this repository.
Harris, M;
Albers, E;
Swan, T;
(2015)
The promise of treatment as prevention for hepatitis C: Meeting the needs of people who inject drugs?
The International journal on drug policy.
ISSN 0955-3959
DOI: https://doi.org/10.1016/j.drugpo.2015.05.005
Full text not available from this repository.
Wolfe, D;
Luhmann, N;
Harris, M;
Momenghalibaf, A;
Albers, E;
Byrne, J;
Swan, T;
(2015)
Human rights and access to hepatitis C treatment for people who inject drugs.
The International journal on drug policy.
ISSN 0955-3959
DOI: https://doi.org/10.1016/j.drugpo.2015.05.007
Full text not available from this repository.
2014
Harris, M;
Forseth, K;
Rhodes, T;
(2014)
"It's Russian roulette": Adulteration, adverse effects and drug use transitions during the 2010/2011 United Kingdom heroin shortage.
The International journal on drug policy, 26 (1).
pp. 51-8.
ISSN 0955-3959
DOI: https://doi.org/10.1016/j.drugpo.2014.09.009
Full text not available from this repository.
Harris, M;
McDonald, B;
Rhodes, T;
(2014)
Hepatitis C testing for people who inject drugs in the United Kingdom: Why is uptake so low?
Drugs (Abingdon, England), 21 (4).
pp. 333-342.
ISSN 0968-7637
DOI: https://doi.org/10.3109/09687637.2014.899988
Full text not available from this repository.
Lazarus, JV;
Lundgren, J;
Casabona, J;
Wiessing, L;
Matheï, C;
Vickerman, P;
Prins, M;
Kretzschmar, M;
Kantzanou, M;
Giraudon, I;
+10 more...
Ferri, M;
Griffiths, P;
Harris, M;
Walker, M;
Chavdarova, L;
Schatz, E;
Schiffer, K;
Kools, JP;
Farell, J;
Mendão, L;
(2014)
Roundtable discussion: how lessons learned from HIV can inform the global response to viral hepatitis.
BMC infectious diseases, 14 (Suppl 6).
S18-S18.
ISSN 1471-2334
DOI: https://doi.org/10.1186/1471-2334-14-S6-S18
Treloar, C;
Gray, R;
Brener, L;
Jackson, C;
Saunders, V;
Johnson, P;
Harris, M;
Butow, P;
Newman, C;
(2014)
“I can’t do this, it’s too much”: building social inclusion in cancer diagnosis and treatment experiences of Aboriginal people, their carers and health workers.
International journal of public health, 59 (2).
pp. 373-379.
ISSN 1661-8556
DOI: https://doi.org/10.1007/s00038-013-0466-1
Full text not available from this repository.
2013
Harris, M;
Rhodes, T;
(2013)
Methadone diversion as a protective strategy: The harm reduction potential of 'generous constraints'.
The International journal on drug policy, 24 (6).
e43-50.
ISSN 0955-3959
DOI: https://doi.org/10.1016/j.drugpo.2012.10.003
Full text not available from this repository.
2010
Treloar, C;
Newland, J;
Harris, M;
Deacon, R;
Maher, L;
(2010)
A diagnosis of hepatitis C: insights from a study on patients' experiences.
Australian Family Physican, 39 (8).
pp. 589-592.
http://researchonline.lshtm.ac.uk/id/eprint/3123
Full text not available from this repository.
2009
Harris, M;
(2009)
Relapse to injecting drug use: A hepatitis C treatment concern.
Contemporary drug problems, 36 (1/2).
p. 303.
ISSN 0091-4509
http://proquest.umi.com/pqdlink?did=1924268531&Fmt...
Full text not available from this repository.